🔴 GT Biopharma is trading 5.65% down today with no clear company-specific catalyst

GT Biopharma is trading at $0.27 (-5.65%) after no clear company-specific catalyst emerged on September 3, 2026.

• No dated company announcement, filing, earnings release, or clinical update explains the decline.
• A Zacks page updated September 3 displayed a Buy upgrade, but its publication date was unavailable and it did not establish causation.
• The broader biotech sector and major indexes are rising, so sector or global sentiment does not explain the drop.